The SD Ireland Rsearch Fund supports administraive costs of research which allows a larger percentage of contributions to go directly to research, making this an especially worthy cause. The team at University of Vermont is working to develop antibodies based on individual breast cancer patients' immune systems in a long and intensie process to develop true, personalized anticancer drugs.
In 1993, Dr. Krag developed the radio-tracer technique for sentinel node surgery which allows the surgeon to accurately identify cancer containing lymph nodes and to accurately remove them. In 1998 he invented and developed a wireless implant able beacon to mark the precise position of cancer for more accurate radiation treatments.
You can read more about Dr. Krag and his team at the University of Vermont at http://sdicancerresearch.org/the-lab/research